A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients (Q57218522)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

title

A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

0 references

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Olivier Hermine

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Rousselot P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Larghero J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Arnulf B

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Poupon J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Royer B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Tibi A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Madelaine-Chambrin I

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Cimerman P

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Dombret H

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Claude Brouet J

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

Paul Fermand J

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1518-1521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15269785 AND SRC:MED&resulttype=core&format=json

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

The biology of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Clinical activity of arsenic trioxide for the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403424